Name: MapLight Therapeutics, Inc. (MPLT) Cash Flow Statement
Creator: FinSpry

MapLight Therapeutics Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for MapLight Therapeutics, Inc. (MPLT) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022
Period Ending	Dec 2024	Dec 2023	Dec 2022
Operating Activities
Net Income	-77.58	-55.71	-30.02
Depreciation & Amortization	0.70	0.56	0.57
Stock Based Compensation	1.08	1.05	1.36
Change in Working Capital	-3.07	2.04	1.72
Change in Accounts Payable	-1.35	-0.41	1.33
Change in Other Working Capital	-0.76	4.11	-1.46
Other Operating Activities	0.75	0.53	0.57
Net Cash from Operating Activities	-78.82	-52.01	-26.58
Investing Activities
Capital Expenditures	-0.77	-0.46	-0.75
Purchases of Investments	-80.02	0.00	0.00
Sales/Maturities of Investments	45.00	0.00	0.00
Net Cash from Investing Activities	-80.79	-0.46	-0.75
Financing Activities
Common Stock Issued	0.29	0.04	0.01
Other Financing Activities	-2.19	0.00	-0.02
Net Cash from Financing Activities	118.06	104.57	33.18
Summary
Effect of Forex Changes on Cash	0.03	0.00	0.00
Net Change in Cash	-41.54	52.10	5.85
Cash at Beginning of Period	79.77	0.00	0.00
Cash at End of Period	38.25	0.00	0.00
Free Cash Flow	-79.59	-52.47	-27.32